C4 Therapeutics, Inc. (CCCC) Financials

CCCC Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 376.5 million 130.3 million
2023-09-30 333.0 million 117.0 million
2023-06-30 375.0 million 141.3 million
2023-03-31 396.0 million 133.6 million

CCCC Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -24.2 million 6.4 million
2023-09-30 -31.3 million 8.2 million
2023-06-30 -19.4 million 6.4 million
2023-03-31 -33.7 million 6.3 million

CCCC Net Income

No data available :(

CCCC Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 253.7 million - 71.0 million
2023-09-30 216.6 million - 72.2 million
2023-06-30 286.7 million - 73.4 million
2023-03-31 305.0 million - 74.5 million

CCCC Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 51.2 million
2023-09-30 49.2 million
2023-06-30 49.1 million
2023-03-31 49.0 million

CCCC Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 157000 30.4 million 10.3 million 1.7 million
2023-09-30 600000 28.3 million 10.5 million -
2023-06-30 362000 29.9 million 10.3 million -
2023-03-31 589000 29.0 million 10.9 million -

CCCC Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 3.3 million 1.7 million
2023-09-30 11.1 million 2.0 million
2023-06-30 2.7 million 2.0 million
2023-03-31 3.8 million 2.1 million

CCCC

Price: $6.61

52 week price:
1.06
11.88

Earnings Per Share: -2.67 USD

P/E Ratio: -1.95

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 914600

Market Capitalization: 515.9 million

Links: